BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
CLSA reinitiates Torrent Pharmaceuticals with buy
CLSA says company gaining ground in India & Brazil and earnings momentum set to accelerate. Improving product mix to help margins and strong core earnings growth key, adds CLSA.